Panelists

Bio

I am a father of three (Juan Alejandro, Isabella and Marianna). After training and working for 11 years as an emergency physician/intensivist in the USA, the opportunity presented to return to my home country of the Dominican Republic where I work on healthcare innovation and medical travel/international medicine. My areas of expertise are Healthcare systems, Management, Global Health, Trauma care, EMS/Disaster and Critical Care. I am the Emergency Medicine Academic Affairs Director at Jackson Memorial Hospital, I also co-founded and directed the Operational Medicine Institute at Harvard MFP (www.opmedinstitute.org).

Work Locations

  • Afghanistan
  • Dominican Republic
  • United States

Organizations

  • Healthcare Management Solutions/ Centers for Global Health and International Medicine
  • Jackson Memorial Hospital

Bio

Dr. Komaromy is an Associate Professor of Medicine and Associate Director of the ECHO Institute (echo.unm.edu), which is a program based at the University of New Mexico Health Sciences Center that is aimed at expanding access to treatment for traditionally underserved populations. She is Director for the Integrated Addictions and Psychiatry teleECHO program, which engages and supports primary care teams in treating addiction and behavioral health disorders. Through this program she has trained more than 500 physicians to provide buprenorphine treatment for opioid use disorder. She is board certified in Addiction Medicine through the American Society of Addiction Medicine. She serves on several national committees focused on addiction medicine. She practices addiction medicine in a primary care outpatient clinic setting, and is the incoming President of the NM Society of Addiction Medicine. She has served as medical director for the NM State Addiction Treatment Hospital. She lectures nationally on clinical and health policy issues related to integration of addiction treatment into the primary care setting, and on the use of the ECHO model to train primary care providers to treat common, complex diseases such as behavioral health and substance use disorders.

Work Location

  • United States

Organization

  • University of New Mexico
Mara Laderman

Mara Laderman

Panelist

Bio

Mara Laderman, MSPH, is a Senior Research Associate at the Institute for Healthcare Improvement (IHI). She leads IHI’s work in behavioral health, developing content and programming to improve behavioral health care. In addition, as a member of IHI’s innovation team, she researches, tests, and disseminates innovative content to advance IHI’s strategic priorities. Prior to IHI, she served as an external program evaluator for the Centers for Disease Control and Prevention and the Massachusetts Department of Public Health. At the Center for Multicultural Mental Health Research, she managed the National Latino and Asian American Study (NLAAS), a nationally representative psychiatric epidemiologic survey that investigated the effect of social and environmental factors on the mental health outcomes of Latinos and Asian Americans. Ms. Laderman received a Master of Public Health from the Harvard School of Public Health and a Bachelor of Arts in Psychology from Smith College.

Work Location

  • United States

Organization

  • Institute for Healthcare Improvement
Anna Lembke

Anna Lembke

Panelist

Bio

Dr. Anna Lembke, MD, is Assistant Professor at the department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is the Program Director for the Stanford Addiction Medicine Fellowship and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Dr. Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She completed a residency in Psychiatry, and a fellowship in mood disorders at the Stanford School of Medicine. She is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine. Dr. Lembke's key areas of interest include treating patients who have become addicted to prescription drugs, including research into patterns of physician opioid prescribing. She takes a holistic, harm-reduction approach to each patient, and encourages spiritual and alternative therapies in the process of healing. Dr. Lembke has developed multiple teaching programs on drug misuse and addiction therapy. She has held multiple leadership and mentorship positions and has received Stanford’s Chairman’s Award for Clinical Innovation. She has chaired the Planning Committee for the California Society of Addiction Medicine (CSAM) Annual Addiction Medicine Conference. She is the president of the Addiction Medicine Fellowship Directors Association (AMFDA). She has published over 50 peer-reviewed articles, chapters, and commentaries, including in the New England Journal of Medicine, the Journal of the American Medical Association, the Journal of General Internal Medicine, American Family Physician, and Addiction. She is the author of a new book on the prescription drug epidemic: Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop (Johns Hopkins University Press, November 2016).

Work Location

  • United States

Organization

  • Stanford University, School of Medicine

Bio

Trained in internal medicine and preventive medicine, Dr. Liebschutz is a primary care physician, substance use researcher, educator, and administrator. Her research agenda focuses on the intersection of substance use, violence, and mental health within the practice of general medical care, with particular focus on opioid prescribing for chronic pain and treatment of opioid use disorders in general medical settings. She directs a large interdisciplinary research training postdoctoral fellowship program for primary care-trained physicians. She serves as Associate Chief for the Section of General Internal Medicine, and the Wellness Director for the Medical-Dental Staff at an academic safety-net hospital. She has mentored dozens of trainees from undergraduates to junior faculty level on research in addiction medicine. She is a national lecturer and educator on opioid prescribing, and the developer of the website, www.mytopcare.org, a resource for opioid prescribing in the primary care setting. She has been a certified buprenorphine prescriber since 2006, managing an active panel of opioid-dependent patients within her primary care practice. Dr. Liebschutz has contributed her expertise in primary care treatment of pain, injection drug use, addiction, and safe prescribing of opioids as Principal Investigator and Co-Investigator on various NIH-funded randomized controlled trials. Her clinical experience, in conjunction with national work on implementing cutting-edge strategies for opioid management in general medical settings, make her well-suited to serve on this expert panel.

Work Location

  • United States

Organization

  • Boston Medical Center - BMC

Bio

Dr London is a Family Medicine physician in Milbridge, ME. Prior to moving to Maine she was an Assistant Professor at Weill Cornell Medical College in New York City. Before her tenure in New York she had her own practice in Brookline, MA and was a Clinical Instructor for Boston University and Tufts University schools of medicine. Her practice is in Washington County Maine, which unfortunately has the highest per capita rate of opioid addiction in the nation. Dr London treats addiction in her practice and has served as medical director of local methadone clinics as well. Dr London has also consulted to the supplement industry.

Work Location

  • United States

Organization

  • Doctors for America
Christine Pace

Christine Pace

Panelist

Bio

Christine Pace, MD, MSc is a primary care physician and addiction specialist. She is an Assistant Professor of Medicine at Boston University Medical School, and the Medical Director of Behavioral Health Integration and Associate Medical Director of Adult Primary Care at Boston Medical Center. She graduated from Harvard Medical School in 1997. She completed a residency in Primary Care Internal Medicine at Brigham and Women's Hospital in 2010, and a fellowship in Addiction Medicine at Boston University School of Medicine/Boston Medical Center in 2012. In additional to her clinical and administrative roles at BMC, she has successfully integrated primary care into several local substance use treatment settings including a methadone clinic and the Boston Public Health Commission's Wellness Project. Her areas of focus are medication-assisted treatment for substance use disorders; care for pregnant and post-partum women with opioid use disorders; and the integration of primary medical care with care for substance use disorders and other behavioral health conditions.

Work Location

  • United States

Organization

  • Boston Medical Center

Bio

Alexander Y. Walley, M.D., M.Sc., is an Associate Professor of Medicine at Boston University School of Medicine and a general internist and addiction medicine specialist at Boston Medical Center. He is the director of the Boston University Addiction Medicine Fellowship program, which trains addiction medicine specialist physicians. He is the founded the Inpatient Addiction Consult Service in 2015 and is the associate director of the Faster Paths addiction urgent care center at Boston Medical Center. He does clinical and research-related work on the medical complications of substance use, specifically HIV and overdose. He provides primary care and office-based addiction treatment for patients with HIV at Boston Medical Center and methadone maintenance treatment at Health Care Resource Centers. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program. Since 2007, the MDPH program has trained over 48,000 people in Massachusetts’s communities, including people who use opioids, people in recovery, and their social networks.

Work Location

  • United States

Organizations

  • Boston Medical Center
  • Boston Medical Center - BMC